JP2018501209A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018501209A5 JP2018501209A5 JP2017527370A JP2017527370A JP2018501209A5 JP 2018501209 A5 JP2018501209 A5 JP 2018501209A5 JP 2017527370 A JP2017527370 A JP 2017527370A JP 2017527370 A JP2017527370 A JP 2017527370A JP 2018501209 A5 JP2018501209 A5 JP 2018501209A5
- Authority
- JP
- Japan
- Prior art keywords
- dihydro
- imidazol
- pyrrolo
- imidazo
- pyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc(cc1)n[n]2c1nc(*)c2 Chemical compound Cc(cc1)n[n]2c1nc(*)c2 0.000 description 36
- LUYISICIYVKBTA-UHFFFAOYSA-N Cc(cc1)cc2c1nccc2 Chemical compound Cc(cc1)cc2c1nccc2 LUYISICIYVKBTA-UHFFFAOYSA-N 0.000 description 3
- NCRHHMSPXYGMIR-UHFFFAOYSA-N Cc1c[n]2ncnc2cc1 Chemical compound Cc1c[n]2ncnc2cc1 NCRHHMSPXYGMIR-UHFFFAOYSA-N 0.000 description 3
- DCUNRLLJHAWKRZ-UHFFFAOYSA-N Cc(cc1)cc2c1[nH]nc2 Chemical compound Cc(cc1)cc2c1[nH]nc2 DCUNRLLJHAWKRZ-UHFFFAOYSA-N 0.000 description 2
- HMMPHXCOTBASBC-UHFFFAOYSA-N Cc1cc([nH]nc2)c2cc1 Chemical compound Cc1cc([nH]nc2)c2cc1 HMMPHXCOTBASBC-UHFFFAOYSA-N 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462082959P | 2014-11-21 | 2014-11-21 | |
| US62/082,959 | 2014-11-21 | ||
| US201562141509P | 2015-04-01 | 2015-04-01 | |
| US62/141,509 | 2015-04-01 | ||
| PCT/US2015/060872 WO2016081364A1 (en) | 2014-11-21 | 2015-11-16 | Fused imidazole derivatives as tgf-beta inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018501209A JP2018501209A (ja) | 2018-01-18 |
| JP2018501209A5 true JP2018501209A5 (enExample) | 2018-12-27 |
| JP6789941B2 JP6789941B2 (ja) | 2020-11-25 |
Family
ID=54704137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017527370A Expired - Fee Related JP6789941B2 (ja) | 2014-11-21 | 2015-11-16 | Ｔｇｆ−ベータ阻害剤としての縮合イミダゾール誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10696693B2 (enExample) |
| EP (1) | EP3221318B1 (enExample) |
| JP (1) | JP6789941B2 (enExample) |
| CN (1) | CN107207531B (enExample) |
| ES (1) | ES2895626T3 (enExample) |
| WO (1) | WO2016081364A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110291089B (zh) | 2017-01-17 | 2022-05-27 | 海帕瑞吉尼克斯股份有限公司 | 用于促进肝再生或者减少或预防肝细胞死亡的蛋白激酶抑制剂 |
| ES3053505T3 (en) | 2017-03-23 | 2026-01-22 | Clavius Pharmaceuticals Llc | Tri-substituted imidazoles for the inhibition of tgf beta and methods of treatment |
| US12077548B2 (en) | 2018-08-22 | 2024-09-03 | Clavius Pharmaceuticals, LLC. | Substituted imidazoles for the inhibition of TGF-β and methods of treatment |
| AU2019396360A1 (en) | 2018-12-11 | 2021-05-27 | Theravance Biopharma R&D Ip, Llc | Naphthyridine and quinoline derivatives useful as ALK5 inhibitors |
| IL293084A (en) | 2019-11-22 | 2022-07-01 | Theravance Biopharma R& D Ip Llc | Substituted 1,5-naphthyridines or quinolines as alk5 inhibitors |
| KR102801205B1 (ko) * | 2019-12-04 | 2025-04-29 | 허난 즈웨이 바이오메디슨 씨오., 엘티디. | 브루톤 티로신 키나제 억제제인 이미다졸 카복사마이드 유도체 |
| WO2021138391A1 (en) | 2019-12-30 | 2021-07-08 | Tyra Biosciences, Inc. | Indazole compounds |
| EP4514802A1 (en) | 2022-04-27 | 2025-03-05 | Chiesi Farmaceutici S.p.A. | Imidazole derivatives as alk5 inhibitors |
| WO2023247592A1 (en) | 2022-06-22 | 2023-12-28 | Chiesi Farmaceutici S.P.A. | 5-(4-fluorophenyl)-2,3-dihydro-1h-imidazo[1,2-a]imidazole derivatives as alk inhibitors for the treatment of fibrosis |
| AU2023320660A1 (en) * | 2022-08-08 | 2025-02-27 | Medinno Pharmaceutical Technology (Zhuhai) Co., Ltd. | TGF-β INHIBITOR COMPOUND AND USE THEREOF |
| PL248267B1 (pl) * | 2023-04-13 | 2025-11-17 | Univ Medyczny W Lublinie | 1-arylo-6-hydroksyimino-5(1H)okso-2,3-dihydroimidazo[1,2-a] imidazole oraz sposób ich wytwarzania oraz ich zastosowanie |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ513642A (en) | 1999-01-21 | 2004-02-27 | Metamorphix Inc | Growth differentiation factor inhibitors and uses therefor |
| RU2264403C2 (ru) * | 1999-11-10 | 2005-11-20 | Орто-Макнейл Фармасьютикал, Инк. | Замещенные 2-арил-3-(гетероарил) имидазо [1,2-а] пиримидины, содержащие их фармацевтические композиции и связанные с ними способы |
| US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
| AU2003256297A1 (en) * | 2002-08-09 | 2004-02-25 | Eli Lilly And Company | Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| EP1567527A1 (en) * | 2002-11-27 | 2005-08-31 | Eli Lilly And Company | Condensed pyrazolo derivatives |
| PA8595001A1 (es) * | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
| WO2007076086A2 (en) * | 2005-12-22 | 2007-07-05 | Biogen Idec Ma Inc | Tricyclic spiro compounds useful as transforming growth factor modulators |
| MX2009003650A (es) * | 2006-10-06 | 2009-04-22 | Abbott Lab | Nuevos imidazotiazoles e imidazoxazoles. |
| WO2009005675A1 (en) * | 2007-06-28 | 2009-01-08 | Abbott Laboratories | Novel triazolopyridazines |
| AU2012281281B2 (en) * | 2011-07-13 | 2017-06-01 | Tiumbio Co., Ltd | 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| JP6267231B2 (ja) * | 2012-12-21 | 2018-01-24 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | カゼインキナーゼ１δ／ε阻害剤としての新規な置換イミダゾール |
| BR112016012129A8 (pt) * | 2013-12-11 | 2020-05-12 | Pfizer Ltd | métodos para produção, expansão e purificação de células epiteliais do pigmento da retina, composição farmacêutica e uso das células |
-
2015
- 2015-11-16 EP EP15801080.1A patent/EP3221318B1/en active Active
- 2015-11-16 ES ES15801080T patent/ES2895626T3/es active Active
- 2015-11-16 CN CN201580074061.5A patent/CN107207531B/zh not_active Expired - Fee Related
- 2015-11-16 US US15/527,908 patent/US10696693B2/en active Active
- 2015-11-16 WO PCT/US2015/060872 patent/WO2016081364A1/en not_active Ceased
- 2015-11-16 JP JP2017527370A patent/JP6789941B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115956080B (zh) | 双环化合物，包含其的组合物及其应用 | |
| AU2019280356B2 (en) | ERK inhibitor and use thereof | |
| AU2016226468B2 (en) | TGF-beta inhibitors | |
| JP2018510857A5 (enExample) | ||
| KR102841843B1 (ko) | 트리아졸로-피리미딘 화합물 및 그의 용도 | |
| WO2022157629A1 (en) | Pharmaceutical combinations of sos1 inhibitors for treating and/or preventing cancer | |
| KR102007056B1 (ko) | 과증식성 질환 치료시 Bub1 키나제 저해제로 사용하기 위한 치환된 벤질인다졸 | |
| KR20180134983A (ko) | Ret 키나아제 억제제로서의 헤테로사이클릭 화합물 | |
| JP6789941B2 (ja) | Ｔｇｆ−ベータ阻害剤としての縮合イミダゾール誘導体 | |
| CA3198809A1 (en) | Heterocyclic spiro compounds and methods of use | |
| AU2019390863B2 (en) | Heterocyclic compound | |
| RU2019120986A (ru) | Фармацевтическая комбинация, содержащая ингибитор alk и ингибитор shp2 | |
| EP4237086A1 (en) | Heterocyclic spiro compounds and methods of use | |
| CA3107365A1 (en) | Pyrazine compounds and uses thereof | |
| CN119768403A (zh) | 作为ddr抑制剂用于治疗纤维化病症和癌症的吡啶并吡唑类 | |
| CN114989173B (zh) | 咪唑类化合物、其药物组合物及其用途 | |
| US20260109699A1 (en) | Azole derivatives as shp2 inhibitors | |
| CA3269027A1 (en) | Azole derivatives as shp2 inhibitors | |
| TWI624461B (zh) | 喹唑啉化合物，其製備方法及用途 | |
| CN119585263A (zh) | 苯基取代的二氢蔡咤类化合物及其制备与用途 |